This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 29/2/246    most recent ATVBAHA.108.179218v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Monzack, E. L. Articles by Masters, K. S. Search for Related Content PubMed PubMed Citation Articles by Monzack, E. L. Articles by Masters, K. S.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:246.)
© 2009 American Heart Association, Inc.

Cell Biology/Signaling

Efficacy of Simvastatin Treatment of Valvular Interstitial Cells Varies With the Extracellular Environment

Elyssa L. Monzack; Xiaoxiao Gu; Kristyn S. Masters

From the Department of Biomedical Engineering, University of Wisconsin-Madison.

Correspondence to Kristyn S. Masters, PhD, University of Wisconsin-Madison, Department of Biomedical Engineering, 1550 Engineering Drive, #2152, Madison, WI 53706. E-mail kmasters{at}wisc.edu

Objective— The lack of therapies that inhibit valvular calcification and the conflicting outcomes of clinical studies regarding the impact of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors on valve disease highlight the need for controlled investigations to characterize the interactions between HMG-CoA reductase inhibitors and valve tissue. Thus, we applied multiple in vitro disease stimuli to valvular interstitial cell (VIC) cultures and examined the impact of simvastatin treatment on VIC function.

Methods and Results— VICs were cultured on 3 different substrates that supported various levels of nodule formation. Transforming growth factor (TGF)-β1 was also applied as a disease stimulus to VICs on 2-D surfaces or encapsulated in 3-D collagen gels and combined with different temporal applications of simvastatin. Simvastatin inhibited calcific nodule formation in a dose-dependent manner on all materials, although the level of statin efficacy was highly substrate-dependent. Simvastatin treatment significantly altered nodule morphology, resulting in dramatic nodule dissipation over time, also in a substrate-dependent manner. These effects were mimicked in 3-D cultures, wherein simvastatin reversed TGF-β1–induced contraction. Decreases in nodule formation were not achieved via the HMG-CoA reductase pathway, but were correlated with decreases in ROCK activity.

Conclusions— These studies represent a significant contribution to understanding how simvastatin may impact heart valve calcification.

Key Words: heart valves • valvular interstitial cells • simvastatin • calcification • extracellular matrix

This article has been cited by other articles:

				J. A. Benton, H. B. Kern, L. A. Leinwand, P. D. Mariner, and K. S. Anseth Statins Block Calcific Nodule Formation of Valvular Interstitial Cells by Inhibiting {alpha}-Smooth Muscle Actin Expression Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1950 - 1957. [Abstract] [Full Text] [PDF]

				C. Y. Y. Yip, J.-H. Chen, R. Zhao, and C. A. Simmons Calcification by Valve Interstitial Cells Is Regulated by the Stiffness of the Extracellular Matrix Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 936 - 942. [Abstract] [Full Text] [PDF]

				X. Gu and K. S. Masters Role of the MAPK/ERK pathway in valvular interstitial cell calcification Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1748 - H1757. [Abstract] [Full Text] [PDF]